US6007845A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
Assignee: Massachusetts Institute of Technology
•
Filing: 1994-07-22
•
Granted: 1999-12-28
•
Expires: 2014-07-22
Abstract
Abstract Particles are provided that are not rapidly cleared from the blood stream by the macrophages of the reticuloendothelial system, and that can be modified to achieve variable release rates or to target specific cells or organs. The particles have a core of a multiblock copolymer formed by covalently linking a multifunctional compound with one or more hydrophobic polymers and one or more hydrophilic polymers, and contain a biologically active material. The terminal hydroxyl group of the poly(alkylene glycol) can be used to covalently attach onto the surface of the particles biologically active molecules, including antibodies targeted to specific cells or organs, or molecules affecting the charge, lipophilicity or hydrophilicity of the particle. The surface of the particle can also be modified by attaching biodegradable polymers of the same structure as those forming the core of the particles. The typical size of the particles is between 180 nm and 10,000 nm, preferably between 180 nm and 240 nm, although microparticles can also be formed as described herein. The particles can include magnetic particles or radiopaque materials for diagnostic imaging, biologically active molecules to be delivered to a site, or compounds for targeting the particles. The particles have a prolonged half-life in the blood compared to particles not containing poly(alkylene glycol) moieties on the surface.
Inventors
- 👤 Abraham J. Domb
- 👤 Ruxandra Gref
- 👤 Yoshiharu Minamitake
- 👤 Maria Teresa Peracchia
- 👤 Robert S. Langer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 20:38
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/513; A61K9/5146; A61K9/5153; Y; Y10; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984; Y10T428/2985; Y10T428/2989
Claims Analysis
Total Claims: 42
Claim 1
Independent Claim
31 words
Multiblock copolymers comprising a multifunctional compound covalently linked to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.
Claim 2
Dependent Claim
31 words
Multiblock copolymers comprising a multifunctional compound covalently linked to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.
Claim 3
Dependent Claim
37 words
The multiblock copolymer of claim 1 wherein the multifunctional compound is selected from the group consisting of dextrins, pentaerythritol, glucaronic acid, tartaric acid, mucic acid, citric acid, benzene tricarboxylic acid, benzene tetracarboxylic acid and butane diglycidyl ether.
Claim 4
Dependent Claim
28 words
The multiblock copolymer of claim 1 wherein the hydrophilic polymer is selected from the group consisting of polyalkylene glycols, polyvinyl alcohols, polypyrrolidones, poly(amino acids), oxidized cellulose and dextrans.
Claim 5
Dependent Claim
22 words
The multiblock copolymer of claim 3 wherein the poly(amino acids) are selected from the group consisting of gelatin, fibrinogen and albumin fragments.
Claim 6
Dependent Claim
38 words
The multiblock copolymer of claim 1 wherein the hydrophobic polymer is selected from the group consisting of polyphosphazenes, polyphosphate esters, polyanhydrides, polyhydroxybutyric acid, polyorthoesters, polycaprolactone, poly(α-hydroxy acids), polybutylene glycol and copolymers prepared from the monomers of these polymers.
Claim 7
Dependent Claim
55 words
A particle having a diameter of between 50 nm and 1000 μm formed of or coated with a multiblock copolymer formed by covalently linking a multifunctional compound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers to form a coblock polymer.
Claim 8
Dependent Claim
55 words
A particle having a diameter of between 50 nm and 1000 μm formed of or coated with a multiblock copolymer formed by covalently linking a multifunctional compound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers to form a coblock polymer.
Claim 9
Dependent Claim
43 words
The particle of claim 6 further comprising a substance to be delivered selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccharides, combinations thereof, and synthetic inorganic or organic molecules that cause a biological effect when administered to an animal.
Claim 10
Dependent Claim
27 words
The particle of claim 6 wherein the hydrophilic polymer is selected from the group consisting of polyalkylene glycols, polyvinyl alcohols, polypyrrolidones, poly(amino acids), oxidized cellulose and dextrans.
Claim 11
Dependent Claim
21 words
The particle of claim 8 wherein the poly(amino acid) is selected from the group consisting of gelatin, fibrinogen and albumin fragments.
Claim 12
Dependent Claim
21 words
The particle of claim 8 wherein the polyalkylene glycol is selected from the group consisting of polyethylene glycol and polyoxyethylene/polyoxypropylene copolymers.
Claim 13
Dependent Claim
35 words
The particle of claim 6 wherein the hydrophobic polymer is selected from the group consisting of polyphosphazenes, polyphosphate esters, polyanhydrides, polyhydroxybutyric acid, polyorthoesters, polycaprolactone, poly(α-hydroxy acids) and copolymers prepared from the monomers of these polymers.
Claim 14
Dependent Claim
36 words
The particle of claim 6 wherein the multifunctional compound is selected from the group consisting of dextrins, pentaerythritol, glucaronic acid, tartaric acid, mucic acid, citric acid, benzene tricarboxylic acid, benzene tetracarboxylic acid and butane diglycidyl ether.
Claim 15
Dependent Claim
55 words
The particle of claim 6 comprising molecules covalently bound to the surface of the particle via reactive groups on the hydrophilic polymer, wherein the molecules are selected from the group consisting of biologically active molecules, non-biologically active molecules which can be detected, targeting molecules, and molecules affecting the charge, lipophilicity or hydrophilicity of the particle.
Claim 16
Dependent Claim
28 words
The particle of claim 13, wherein the targeting molecule is selected from the group consisting of compounds specifically reactive with a cell surface component, antibodies and antibody fragments.
Claim 17
Dependent Claim
13 words
The particle of claim 6 wherein the diameter is less than one micron.
Claim 18
Dependent Claim
14 words
The particle of claim 6 wherein the diameter is between one and 1000 microns.
Claim 19
Dependent Claim
27 words
The particle of claim 13 wherein the detectable molecule is selected from the group consisting of substances detectable by x-ray, fluorescence, ultrasound, magnetic resonance imaging and radioactivity.
Claim 20
Dependent Claim
12 words
The particle of claim 8, wherein the poly(alkylene glycol) is poly(ethylene glycol).
Claim 21
Dependent Claim
18 words
The particle of claim 6 formed of a core of a different material than the coblock polymer coating.
Claim 22
Independent Claim
36 words
A method for making a multiblock copolymer by covalently linking a multifunctional compound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.
Claim 23
Independent Claim
36 words
A method for making a multiblock copolymer by covalently linking a multifunctional compound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.
Claim 24
Dependent Claim
40 words
The method of claim 20 further comprising forming a particle with a diameter between 50 nm and 1000 μm of the coblock polymer or coating a particle with a diameter between 50 nm and 1000 μm with the coblock polymer.
Claim 25
Dependent Claim
13 words
The method of claim 21 further comprising incorporating a substance in the particle.
Claim 26
Dependent Claim
46 words
The method of claim 22 wherein the substance is a biologically active substance selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccharides, combinations thereof, and synthetic inorganic or organic molecules that cause a biological effect when administered in vivo to an animal.
Claim 27
Dependent Claim
27 words
The method of claim 20 wherein the hydrophilic polymer is selected from the group consisting of polyalkylene glycols, polyvinyl alcohols, polypyrrolidones, poly(amino acids), oxidized cellulose and dextrans.
Claim 28
Dependent Claim
21 words
The method of claim 24 wherein the poly(amino acid) is selected from the group consisting of gelatin, fibrinogen and albumin fragments.
Claim 29
Dependent Claim
35 words
The method of claim 20 wherein the hydrophobic polymer is selected from the group consisting of polyphosphazenes, polyphosphate esters, polyanhydrides, polyhydroxybutyric acid, polyorthoesters, polycaprolactone, poly(α-hydroxy acids) and copolymers prepared from the monomers of these polymers.
Claim 30
Dependent Claim
36 words
The method of claim 20 wherein the multifunctional compound is selected from the group consisting of dextrins, pentaerythritol, glucaronic acid, tartaric acid, mucic acid, citric acid, benzene tricarboxylic acid, benzene tetracarboxylic acid and butane diglycidyl ether.
Claim 31
Dependent Claim
54 words
The method of claim 21 further comprising covalently binding to the surface of the particle via the terminal hydroxyl group of the poly(alkylene glycol) molecules selected from the group consisting of biologically active molecules, non-biologically active molecules which can be detected, targeting molecules, and molecules affecting the charge, lipophilicity or hydrophilicity of the particle.
Claim 32
Dependent Claim
46 words
The method of claim 28 further comprising targeting the particle for delivery to a specific cell type by attaching to the surface of the particle a targeting molecule selected from the group consisting of compounds specifically reactive with a cell surface component, antibodies and antibody fragments.
Claim 33
Dependent Claim
21 words
The method of claim 28 wherein the molecule is a substance detectable by x-ray, fluorescence, magnetic resonance imaging, ultrasound or radioactivity.
Claim 34
Independent Claim
71 words
A method for delivering a substance to a patient comprising administering to the patient a particle having a diameter of between 50 nm and 1000 μm, wherein the particle is formed of or is coated with a multiblock copolymer, the multiblock copolymer comprises a multifinctional compound covalently bound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.
Claim 35
Independent Claim
71 words
A method for delivering a substance to a patient comprising administering to the patient a particle having a diameter of between 50 nm and 1000 μm, wherein the particle is formed of or is coated with a multiblock copolymer, the multiblock copolymer comprises a multifinctional compound covalently bound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.
Claim 36
Dependent Claim
58 words
The method of claim 31 wherein the substance to be delivered is a biologically active substance selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccharides, combinations thereof, synthetic inorganic molecules that cause a biological effect when administered to an animal and synthetic organic molecules that cause a biological effect when administered to an animal.
Claim 37
Dependent Claim
27 words
The method of claim 31 wherein the hydrophilic polymer is selected from the group consisting of polyalkylene glycols, polyvinyl alcohols, polypyrrolidones, poly(amino acids), oxidized cellulose and dextrans.
Claim 38
Dependent Claim
21 words
The method of claim 33 wherein the polyalkylene glycol is selected from the group consisting of polyethylene glycol and polyoxyethylene/polyoxypropylene copolymers.
Claim 39
Dependent Claim
35 words
The method of claim 31 wherein the hydrophobic polymer is selected from the group consisting of polyphosphazenes, polyphosphate esters, polyanhydrides, polyhydroxybutyric acid, polyorthoesters, polycaprolactone, poly(α-hydroxy acids) and copolymers prepared from the monomers of these polymers.
Claim 40
Dependent Claim
36 words
The method of claim 31 wherein the multifunctional compound is selected from the group consisting of dextrins, pentaerythritol, glucaronic acid, tartaric acid, mucic acid, citric acid, benzene tricarboxylic acid, benzene tetracarboxylic acid and butane diglycidyl ether.
Claim 41
Dependent Claim
77 words
The method of claim 22 further comprising delivering a substance to a patient comprising administering the particle to the patient, wherein the substance to be delivered is a biologically active substance selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccharides, combinations thereof, synthetic inorganic molecules that cause a biological effect when administered in vivo to an animal and synthetic organic molecules that cause a biological effect when administered in vivo to an animal.
Claim 42
Dependent Claim
26 words
The method of claim 37, wherein the molecule is selected from the group consisting of substances detectable by x-ray, fluorescence, ultrasound, magnetic resonance imaging and radioactivity.
References Cited (Backward Citations)
US4501726A
Cited
EP0092918A2
Cited
US4801739A
Cited
US4888176A
Cited
EP0166596A2
Cited
US4904479A
Cited
US5141739A
Cited
US4757128A
Cited
US4789724A
Cited
US5133908A
Cited
EP0295055A2
Cited
US4857311A
Cited
US5149543A
Cited
US5410016A
Cited
US5145684A
Cited
EP0520888A1
Cited
EP0520889A1
Cited
EP0552802A2
Cited
WO1994002122A1
Cited
US5565215A
Cited
US5578325A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-12-27 | 2003-06-28 | 2003-12-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-12-27 | 2007-06-28 | 2007-12-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-12-27 | 2011-06-28 | 2011-12-28 | $7700.00 | Window Closed / Lapsed |